Opinion

Video

ARPI-Based Combination Regimens – ARANOTE (Darolutamide and ADT)

Panelists discuss how the ARANOTE trial exploring darolutamide in combination with androgen deprivation therapy shows potential benefits in managing advanced prostate cancer.

Related Videos
Related Content